Md. firm’s treatment earns FDA clearance for Covid patients with drug-resistant infections

The Maryland biotech's virus-based therapy targets superbugs.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.